Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis

Veronika Rauscher, Matthias Englbrecht, Désirée van der Heijde, Georg Schett and Axel J. Hueber
The Journal of Rheumatology March 2015, 42 (3) 386-390; DOI: https://doi.org/10.3899/jrheum.140982
Veronika Rauscher
From the Department of Internal Medicine 3 and the Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; and the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Englbrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Désirée van der Heijde
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georg Schett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel J. Hueber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: axel.hueber@uk-erlangen.de
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 42 no. 3 386-390
DOI 
https://doi.org/10.3899/jrheum.140982
PubMed 
25593229

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication November 10, 2014
  • Published online March 1, 2015.

Article Versions

  • Latest version (January 15, 2015 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2015

Author Information

  1. Veronika Rauscher,
  2. Matthias Englbrecht,
  3. Désirée van der Heijde,
  4. Georg Schett and
  5. Axel J. Hueber⇑
  1. From the Department of Internal Medicine 3 and the Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; and the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
  2. V. Rauscher, Medical Student; M. Englbrecht, Dipl.-Psych. Univ.; G. Schett, MD, Professor; A.J. Hueber, MD, PhD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; D. van der Heijde, MD, Professor, Department of Rheumatology, Leiden University Medical Center.
  1. Address correspondence to Dr. A. Hueber, Department of Internal Medicine 3 and Institute for Clinical Immunology, Universität Erlangen-Nürnberg, Ulmenweg 18, 91054 Erlangen, Germany. E-mail: axel.hueber{at}uk-erlangen.de

Article usage

Article usage: January 2015 to April 2022

AbstractFullPdf
Jan 2015236180
Feb 2015199224
Mar 20158572698
Apr 2015173422
May 2015106910
Jun 2015881113
Jul 20155237
Aug 20158359
Sep 20154023
Oct 20154566
Nov 20153359
Dec 20152658
Jan 20164056
Feb 20162857
Mar 201624615
Apr 20162344
May 20162333
Jun 20162131
Jul 20163333
Aug 20162722
Sep 20162421
Oct 20162201
Nov 20161122
Dec 20164942
Jan 20172955
Feb 20173032
Mar 2017391213
Apr 20171534
May 20172766
Jun 20173243
Jul 20171611
Aug 20173918
Sep 20172811
Oct 20174345
Nov 20172843
Dec 20172933
Jan 20188021
Feb 20184310
Mar 20188221
Apr 20185322
May 20183821
Jun 20183622
Jul 20183800
Aug 20182110
Sep 20181821
Oct 20182701
Nov 20182341
Dec 20182322
Jan 20192400
Feb 20192610
Mar 20191532
Apr 20191000
May 20191800
Jun 20191015
Jul 20191930
Aug 20191411
Sep 20191711
Oct 20192600
Nov 20193700
Dec 20192600
Jan 20202920
Feb 20209112
Mar 20209102
Apr 20205226
May 20201123
Jun 2020642
Jul 20202139
Aug 2020526
Sep 20206103
Oct 2020548
Nov 2020252
Dec 20203111
Jan 2021243
Feb 2021212214
Mar 20211465
Apr 20218102
May 202157645
Jun 2021381
Jul 20213108
Aug 2021555
Sep 20216163
Oct 20214187
Nov 20213102
Dec 20216511
Jan 20222208
Feb 2022363
Mar 202222232
Apr 202214234

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 42, Issue 3
1 Mar 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
Veronika Rauscher, Matthias Englbrecht, Désirée van der Heijde, Georg Schett, Axel J. Hueber
The Journal of Rheumatology Mar 2015, 42 (3) 386-390; DOI: 10.3899/jrheum.140982

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
Veronika Rauscher, Matthias Englbrecht, Désirée van der Heijde, Georg Schett, Axel J. Hueber
The Journal of Rheumatology Mar 2015, 42 (3) 386-390; DOI: 10.3899/jrheum.140982
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • APPENDIX 1.
    • APPENDIX 2.
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

ADHERENCE
COMPLIANCE
RHEUMATOID ARTHRITIS
CQR
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

Related Articles

Cited By...

More in this TOC Section

  • Vasculitis: What Have We Learned in the Last 50 Years?
  • Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)–associated Bronchiectasis: Role of RA-related Autoantibodies
  • Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis
Show more Article

Similar Articles

Keywords

  • ADHERENCE
  • COMPLIANCE
  • rheumatoid arthritis
  • CQR
  • disease-modifying antirheumatic drugs

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire